MINNEAPOLIS — Bio-Techne Corporation (NASDAQ:TECH) today announced the release of GMP ProDots™ Proteins to support cell and gene therapy manufacturing workflows. GMP ProDots™ Proteins address a critical need to precisely dose and safely add essential proteins such as growth factors and cytokines to therapeutic cell cultures. GMP ProDots Proteins, produced under GMP-grade conditions to meet […]

BALTIMORE, MD  – PathSensors Inc., a Baltimore biotechnology company, announced today the completion of Phase I of a Small Business Innovation Research (SBIR) program funded by the National Institute of Food and Agriculture (NIFA) entitled “Food Safety in the 21st Century: Rapid Toxin Detection in the Field”. The project’s goal was to engineer and develop a […]

Vienna, Austria – Today Lexogen, the transcriptomics and next-generation sequencing company, launched the new TraPR Small RNA Isolation Kit. TraPR (Trans-Kingdom, Rapid, Affordable Purification of RISCs) is a breakthrough method that enables a gel free isolation of functional small RNAs (sRNAs) and allows for a cost-efficient, accurate, and highly reproducible analysis of sRNAs that carry important biological information. Regulatory […]

Uppsala, Sweden, June 3, 2020: Olink Proteomics today announces the launch of Olink® Explore 1536, combining the company’s unique proximity extension assay (PEA) high-multiplex technology with next-generation sequencing (NGS) readout on the Illumina® NovaSeq platform. Olink Explore 1536 has several groundbreaking features that overcome significant limitations in other proteomic technologies, including remarkably increased performance in […]

ANN ARBOR, Mich. — Swift Biosciences and Arbor Biosciences, a division of Chiral Technologies, jointly announced a partnership to offer a complete workflow for RNA-Seq library preparation and targeted enrichment of the SARS-CoV-2 genome. An enabling offering for epidemiological research and public health surveillance, the partnership leverages Swift’s patented Adaptase® technology within the Swift RNA […]

Supporting the pharmaceutical industry in providing potential life-saving treatments to patients faster MORRISVILLE, N.C.  – Q2 Solutions, a leading clinical trial laboratory services organization resulting from an IQVIA and Quest Diagnostics joint venture, today announced its partnership with Thermo Fisher Scientific to use the Ion Torrent Genexus System, the first fully integrated, next-generation sequencing (NGS) platform, to […]

LOS ALTOS, CA – Bioz, Inc., a Silicon Valley AI software company, is proud to announce the expansion of its partnership with Jena Bioscience, an established global life science reagent supplier with 8,000 products, and customers in 100+ countries. Jena Bioscience’s reagents are regularly cited in top-tier peer-reviewed journals, with thousands of citations in over 1,000 journals […]

LumaCyte, an advanced bioanalytical instrumentation company has demonstrated a significant advancement using its transformative Laser Force Cytology (LFC) instrument, Radiance®. LumaCyte recently collaborated with global cell and gene therapy leader, Catalent, where their joint teams uncovered valuable new capabilities in the monitoring of adeno-associated virus (AAV) production and infectivity, foundational precursors in the production of […]

HOUSTON — NuProbe, a global precision molecular diagnostics company, announces the world-wide exclusive in-license of two technologies from Rice University. The first, Non-Extensible Oligonucleotides (NEO), will allow NuProbe to provide much more rapid development of customized NGS panels, with turnaround time of less than 4 weeks. The second, Linear DNA Assembly (LDA) technology, improves the effective throughput […]

Expansion of the CAVATICA Platform to Australia Enables Harmonized Analysis of Geographically Separated and Jurisdictionally Protected Data Resources BOSTON —Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced a collaborative partnership between The Gabriella Miller Kids First Data Resource Center (Kids First DRC), ZERO Childhood Cancer (ZERO), the Children’s Brain Tumor Tissue Consortium (CBTTC), the […]